220 related articles for article (PubMed ID: 36436149)
1. NF2 mutations are associated with resistance to radiation therapy for grade 2 and grade 3 recurrent meningiomas.
Vasan V; Dullea JT; Devarajan A; Ali M; Rutland JW; Gill CM; Kinoshita Y; McBride RB; Gliedman P; Bederson J; Donovan M; Sebra R; Umphlett M; Shrivastava RK
J Neurooncol; 2023 Jan; 161(2):309-316. PubMed ID: 36436149
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of NF2 alteration in grade I meningiomas revisited; prognostic impact integrated with extent of resection, tumour location, and Ki-67 index.
Teranishi Y; Okano A; Miyawaki S; Ohara K; Ishigami D; Hongo H; Dofuku S; Takami H; Mitsui J; Ikemura M; Komura D; Katoh H; Ushiku T; Ishikawa S; Shin M; Nakatomi H; Saito N
Acta Neuropathol Commun; 2022 May; 10(1):76. PubMed ID: 35570314
[TBL] [Abstract][Full Text] [Related]
3. First insight into the somatic mutation burden of neurofibromatosis type 2-associated grade I and grade II meningiomas: a case report comprehensive genomic study of two cranial meningiomas with vastly different clinical presentation.
Dewan R; Pemov A; Dutra AS; Pak ED; Edwards NA; Ray-Chaudhury A; Hansen NF; Chandrasekharappa SC; Mullikin JC; Asthagiri AR; ; Heiss JD; Stewart DR; Germanwala AV
BMC Cancer; 2017 Feb; 17(1):127. PubMed ID: 28193203
[TBL] [Abstract][Full Text] [Related]
4. Distinct genomic subclasses of high-grade/progressive meningiomas: NF2-associated, NF2-exclusive, and NF2-agnostic.
Williams EA; Santagata S; Wakimoto H; Shankar GM; Barker FG; Sharaf R; Reddy A; Spear P; Alexander BM; Ross JS; Brastianos PK; Cahill DP; Ramkissoon SH; Juratli TA
Acta Neuropathol Commun; 2020 Oct; 8(1):171. PubMed ID: 33087175
[TBL] [Abstract][Full Text] [Related]
5. Clinical and genomic differences in supratentorial versus infratentorial NF2 mutant meningiomas.
Tabor JK; O'Brien J; Vasandani S; Vetsa S; Lei H; Jalal MI; Marianayagam NJ; Jin L; Millares Chavez M; Haynes J; Dincer A; Yalcin K; Aguilera SM; Omay SB; Mishra-Gorur K; McGuone D; Morales-Valero SF; Fulbright RK; Gunel M; Erson-Omay EZ; Moliterno J
J Neurosurg; 2023 Dec; 139(6):1648-1656. PubMed ID: 37243548
[TBL] [Abstract][Full Text] [Related]
6.
Dullea JT; Chaluts D; Vasan V; Rutland JW; Gill CM; Ellis E; Kinoshita Y; McBride RB; Bederson J; Donovan M; Sebra R; Umphlett M; Shrivastava RK
Br J Neurosurg; 2023 Apr; ():1-7. PubMed ID: 37096420
[TBL] [Abstract][Full Text] [Related]
7. NF2 gene expression in sporadic meningiomas: relation to grades or histotypes real time-pCR study.
Buccoliero AM; Castiglione F; R Degl'Innocenti D; Gheri CF; Garbini F; Taddei A; Ammannati F; Mennonna P; Taddei GL
Neuropathology; 2007 Feb; 27(1):36-42. PubMed ID: 17319281
[TBL] [Abstract][Full Text] [Related]
8. Somatic mutation landscape in a cohort of meningiomas that have undergone grade progression.
Cain SA; Pope B; Mangiola S; Mantamadiotis T; Drummond KJ
BMC Cancer; 2023 Mar; 23(1):216. PubMed ID: 36882706
[TBL] [Abstract][Full Text] [Related]
9. NF2 mutations in secretory and other rare variants of meningiomas.
Hartmann C; Sieberns J; Gehlhaar C; Simon M; Paulus W; von Deimling A
Brain Pathol; 2006 Jan; 16(1):15-9. PubMed ID: 16612978
[TBL] [Abstract][Full Text] [Related]
10. ARID1A mutation associated with recurrence and shorter progression-free survival in atypical meningiomas.
Chaluts D; Dullea JT; Ali M; Vasan V; Devarajan A; Rutland JW; Gill CM; Ellis E; Kinoshita Y; McBride RB; Bederson J; Donovan M; Sebra R; Umphlett M; Shrivastava RK
J Cancer Res Clin Oncol; 2023 Jul; 149(8):5165-5172. PubMed ID: 36348021
[TBL] [Abstract][Full Text] [Related]
11. Genomic analysis of spinal meningiomas: correlation with histopathological grade.
Driver J; Santagata S; Bi WL; Chi JH
J Neurosurg Spine; 2023 Dec; 39(6):729-733. PubMed ID: 37728381
[TBL] [Abstract][Full Text] [Related]
12. Associations of meningioma molecular subgroup and tumor recurrence.
Youngblood MW; Miyagishima DF; Jin L; Gupte T; Li C; Duran D; Montejo JD; Zhao A; Sheth A; Tyrtova E; Özduman K; Iacoangeli F; Peyre M; Boetto J; Pease M; Avşar T; Huttner A; Bilguvar K; Kilic T; Pamir MN; Amankulor N; Kalamarides M; Erson-Omay EZ; Günel M; Moliterno J
Neuro Oncol; 2021 May; 23(5):783-794. PubMed ID: 33068421
[TBL] [Abstract][Full Text] [Related]
13. NF2 mutation status and tumor mutational burden correlate with immune cell infiltration in meningiomas.
Rutland JW; Gill CM; Loewenstern J; Arib H; Pain M; Umphlett M; Kinoshita Y; McBride RB; Bederson J; Donovan M; Sebra R; Shrivastava RK; Fowkes M
Cancer Immunol Immunother; 2021 Jan; 70(1):169-176. PubMed ID: 32661686
[TBL] [Abstract][Full Text] [Related]
14. Clinical impact of targeted amplicon sequencing for meningioma as a practical clinical-sequencing system.
Yuzawa S; Nishihara H; Yamaguchi S; Mohri H; Wang L; Kimura T; Tsuda M; Tanino M; Kobayashi H; Terasaka S; Houkin K; Sato N; Tanaka S
Mod Pathol; 2016 Jul; 29(7):708-16. PubMed ID: 27102344
[TBL] [Abstract][Full Text] [Related]
15. Clinical features and treatment of World Health Organization grade II and III meningiomas in childhood: report of 23 cases.
Wang XQ; Jiang CC; Zhao L; Gong Y; Hu J; Chen H
J Neurosurg Pediatr; 2012 Nov; 10(5):423-33. PubMed ID: 22938082
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant radiation for WHO grade II and III intracranial meningiomas: insights on survival and practice patterns from a National Cancer Registry.
Brown DA; Goyal A; Kerezoudis P; Alvi MA; Himes BT; Bydon M; Van Gompel JJ; Chaichana KL; Quiñones-Hinojosa A; Burns TC; Yan E; Parney IF
J Neurooncol; 2020 Sep; 149(2):293-303. PubMed ID: 32860156
[TBL] [Abstract][Full Text] [Related]
17. Inherited genetic syndromes and meningiomas.
Look A; Lonser RR
Handb Clin Neurol; 2020; 169():121-129. PubMed ID: 32553283
[TBL] [Abstract][Full Text] [Related]
18. Molecular landscapes of longitudinal NF2/22q and non-NF2/22q meningiomas show different life histories.
Ng HK; Li KK; Chung NY; Chan JY; Poon MF; Wong QH; Kwan JS; Poon WS; Chen H; Chan DT; Shi ZF; Mao Y
Brain Pathol; 2023 May; 33(3):e13120. PubMed ID: 36167400
[TBL] [Abstract][Full Text] [Related]
19. Pathology and genetics of meningiomas.
Alahmadi H; Croul SE
Semin Diagn Pathol; 2011 Nov; 28(4):314-24. PubMed ID: 22195409
[TBL] [Abstract][Full Text] [Related]
20. Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO.
Clark VE; Erson-Omay EZ; Serin A; Yin J; Cotney J; Ozduman K; Avşar T; Li J; Murray PB; Henegariu O; Yilmaz S; Günel JM; Carrión-Grant G; Yilmaz B; Grady C; Tanrikulu B; Bakircioğlu M; Kaymakçalan H; Caglayan AO; Sencar L; Ceyhun E; Atik AF; Bayri Y; Bai H; Kolb LE; Hebert RM; Omay SB; Mishra-Gorur K; Choi M; Overton JD; Holland EC; Mane S; State MW; Bilgüvar K; Baehring JM; Gutin PH; Piepmeier JM; Vortmeyer A; Brennan CW; Pamir MN; Kiliç T; Lifton RP; Noonan JP; Yasuno K; Günel M
Science; 2013 Mar; 339(6123):1077-80. PubMed ID: 23348505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
